BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 34944416)

  • 1. The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor.
    Bharadwaj AG; Kempster E; Waisman DM
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
    Kwon M; MacLeod TJ; Zhang Y; Waisman DM
    Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.
    Huang D; Yang Y; Sun J; Dong X; Wang J; Liu H; Lu C; Chen X; Shao J; Yan J
    Front Med; 2017 Sep; 11(3):410-422. PubMed ID: 28687976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10.
    Madureira PA; Bharadwaj AG; Bydoun M; Garant K; O'Connell P; Lee P; Waisman DM
    Oncotarget; 2016 Jul; 7(30):47720-47737. PubMed ID: 27351226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the annexin A2 heterotetramer in vascular fibrinolysis.
    Madureira PA; Surette AP; Phipps KD; Taboski MA; Miller VA; Waisman DM
    Blood; 2011 Nov; 118(18):4789-97. PubMed ID: 21908427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.
    MacLeod TJ; Kwon M; Filipenko NR; Waisman DM
    J Biol Chem; 2003 Jul; 278(28):25577-84. PubMed ID: 12730231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis.
    Madureira PA; O'Connell PA; Surette AP; Miller VA; Waisman DM
    J Biomed Biotechnol; 2012; 2012():353687. PubMed ID: 23118506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annexin A2-S100A10 heterotetramer, a novel substrate of thioredoxin.
    Kwon M; Yoon CS; Jeong W; Rhee SG; Waisman DM
    J Biol Chem; 2005 Jun; 280(25):23584-92. PubMed ID: 15849182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Annexin A2/S100A10 Complex: The Mutualistic Symbiosis of Two Distinct Proteins.
    Bharadwaj A; Kempster E; Waisman DM
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of plasmin generation by S100A10.
    Miller VA; Madureira PA; Kamaludin AA; Komar J; Sharma V; Sahni G; Thelwell C; Longstaff C; Waisman DM
    Thromb Haemost; 2017 Jun; 117(6):1058-1071. PubMed ID: 28382372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the contribution of S100A10 and annexin A2 to plasminogen activation and oncogenesis: an enduring ambiguity.
    Bydoun M; Waisman DM
    Future Oncol; 2014 Dec; 10(15):2469-79. PubMed ID: 25525855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple functions of S100A10, an important cancer promoter.
    Saiki Y; Horii A
    Pathol Int; 2019 Nov; 69(11):629-636. PubMed ID: 31612598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
    Sharma MC; Sharma M
    Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of S100A10 by the PML-RAR-α oncoprotein.
    O'Connell PA; Madureira PA; Berman JN; Liwski RS; Waisman DM
    Blood; 2011 Apr; 117(15):4095-105. PubMed ID: 21310922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen receptors and their role in the pathogenesis of inflammatory, autoimmune and malignant disease.
    Godier A; Hunt BJ
    J Thromb Haemost; 2013 Jan; 11(1):26-34. PubMed ID: 23140188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Ion Channels and Receptors by p11 (S100A10).
    Seo JS; Svenningsson P
    Trends Pharmacol Sci; 2020 Jul; 41(7):487-497. PubMed ID: 32418644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells.
    Hou Y; Yang L; Mou M; Hou Y; Zhang A; Pan N; Qiang R; Wei L; Zhang N
    Cancer Invest; 2008 Oct; 26(8):809-15. PubMed ID: 18608216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of fibrinolysis by S100A10 in vivo.
    Surette AP; Madureira PA; Phipps KD; Miller VA; Svenningsson P; Waisman DM
    Blood; 2011 Sep; 118(11):3172-81. PubMed ID: 21768297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer.
    Noye TM; Lokman NA; Oehler MK; Ricciardelli C
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism of plasminogen activation in epithelial and mesenchymal cells.
    Bydoun M; Sterea A; Weaver ICG; Bharadwaj AG; Waisman DM
    Sci Rep; 2018 Sep; 8(1):14091. PubMed ID: 30237490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.